L. Hebert

L. Hebert, R. Glassock, F. Fervenza, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Bath Salts: A Newly Recognized Cause of Acute Kidney Injury

B. Rovin, L. Hebert, J. McNeely, 2012, Case reports in nephrology.

Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach

B. Rovin, L. Hebert, T. Nadasdy, 2013, American Journal of Nephrology.

Renal artery pressure gradients in patients with angiographic evidence of atherosclerotic renal artery stenosis.

N. Nahman, L. Hebert, D. Spigos, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Characterization of Glomerular Diseases Using Proteomic Analysis of Laser Capture Microdissected Glomeruli

Michael A. Freitas, T Nadasdy, L. Hebert, 2012, Modern Pathology.

A unique familial lobular glomerulopathy.

L. Hebert, W. Bay, H. Sharma, 1987, Archives of pathology & laboratory medicine.

Glomerulopathy associated with predominant fibronectin deposits : a newly recognized hereditary disease

F. Gudat, M. Mihatsch, L. Hebert, 1995 .

Glomerulopathy associated with predominant fibronectin deposits: a newly recognized hereditary disease

F. Gudat, M. Mihatsch, L. Hebert, 1996, Pediatric Nephrology.

Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q

B. Rovin, D. Birmingham, L. Hebert, 2012, Lupus.

Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate.

F. Cosio, D. Birmingham, L. Hebert, 1987, Clinical immunology and immunopathology.

A comparison of taste acuity for salt in renal patients vs. normal subjects.

L. Hebert, R. Hurley, A. B. Rypien, 1987, Journal of the American Dietetic Association.

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Tom Greene, Lawrence J Appel, Lee Hebert, 2002, JAMA.

Relapse or Worsening of Nephrotic Syndrome in Idiopathic Membranous Nephropathy Can Occur even though the Glomerular Immune Deposits Have Been Eradicated

B. Rovin, L. Hebert, T. Nadasdy, 2011, Nephron Clinical Practice.

Rapidly Progressive Glomerulonephritis Superimposed on Diabetic Glomerulosclerosis: Recognition and Treatment

L. Hebert, J. Garancis, W. Piering, 1982 .

Method for detecting a progressive renal disorder superimposed on a preexisting progressive renal disorder.

L. Hebert, P. Mavrelis, W. Piering, 1981, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Reversal of chronic end-stage renal failure due to myeloma kidney.

L. Hebert, W. Brown, J. Garancis, 1979, Annals of internal medicine.

A modest proposal for improving the accuracy of creatinine-based GFR-estimating equations.

P. Hebert, L. Hebert, U. Bhatt, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

High‐sensitivity C‐reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus

B. Rovin, D. Birmingham, L. Hebert, 2013, Arthritis care & research.

Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis.

B. Rovin, D. Birmingham, L. Hebert, 2012, Rheumatology.

Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects.

H. Nagaraja, B. Rovin, D. Birmingham, 2006, Advances in experimental medicine and biology.

Complement Components C4A and C4B in Human Lupus

B. Rovin, D. Birmingham, C. Y. Yu, 2005 .

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.

L. Hebert, G. Appel, W. Hoy, 2001, Kidney international.

Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.

B. Rovin, L. Hebert, S. Brodsky, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Staphylococcus Infection-Associated GN - Spectrum of IgA Staining and Prevalence of ANCA in a Single-Center Cohort.

B. Rovin, L. Hebert, S. Brodsky, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications.

H. Nagaraja, B. Rovin, M. Bissell, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis.

H. Nagaraja, B. Rovin, L. Hebert, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Blood Pressure Control, Proteinuria, and the Progression of Renal Disease

T. Greene, L. Hebert, S. Massry, 1995, Annals of Internal Medicine.

Target blood pressure for antihypertensive therapy in patients with proteinuric renal disease

L. Hebert, 1999, Current hypertension reports.

Disposition of IgA-containing circulating immune complexes.

L. Hebert, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.

L. Hebert, S. Brodsky, T. Nadasdy, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The urgent call of albuminuria/proteinuria

L. Hebert, W. Keane, D. Spetie, 2001, Postgraduate medicine.

My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic kidney disease.

L. Hebert, R. Stahl, U. Wenzel, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Renoprotective therapy: how good can it get?

L. Hebert, Lee A. Hebert, 2000, Kidney International.

On the natural tendency to progressive loss of remaining kidney function in patients with impaired renal function.

L. Hebert, W. Bay, 1990, The Medical clinics of North America.

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.

B. Rovin, L. Juncos, P. Jüni, 2019, The New England journal of medicine.

Limited Reliability of the Spot Urine Protein/Creatinine Ratio in the Longitudinal Evaluation of Patients With Lupus Nephritis

B. Rovin, P. Hebert, L. Hebert, 2018, Kidney international reports.

Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular disease

B. Rovin, D. Fine, M. Bissell, 2013, Annals of the rheumatic diseases.

Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group.

J. Breyer, A. Levey, T. Greene, 1997, Hypertension.

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.

G. Bakris, L. Hebert, I. Janssen, 2000, Kidney international.

Remission of nephrotic range proteinuria in type I diabetes : Forefronts in nephrology

R. Bain, E. Lewis, L. Hebert, 1994 .

Combination ACE Inhibitor and Angiotensin II Receptor Antagonist Therapy in Diabetic Nephropathy

F. Cosio, L. Hebert, T. O'dorisio, 1999, American Journal of Nephrology.

A within-patient analysis for time-varying risk factors of CKD progression.

Jackson T. Wright, B. Astor, L. Appel, 2014, Journal of the American Society of Nephrology.

Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and Whites

J. Breyer, A. Levey, T. Greene, 1997 .

Proposed pathogenesis of idiopathic loin pain-hematuria syndrome.

H. Nagaraja, N. Nahman, L. Hebert, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy.

L. Hebert, W. Bay, G. Agarwal, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Controlled Clinical Trial of Angiotensin-Converting Enzyme Inhibition in Type I Diabetic Nephropathy: Study Design and Patient Characteristics

Mark E. Williams, J. Breyer, R. Bain, 1992 .

Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?

R. Maciuca, B. Rovin, L. Hebert, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Measured GFR has limited clinical utility.

L. Hebert, T. Pesavento, U. Nori, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Retarding Progression of Kidney Disease

L. Hebert, N. Haddad, Chris Brown, 2010 .

Rituximab or azathioprine maintenance in ANCA-associated vasculitis.

B. Rovin, L. Hebert, A. Alvarado, 2015, The New England journal of medicine.

DISEASE OF THE MONTH

B. Rovin, L. Hebert, C. Hebert, 2003 .

The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort

B. Rovin, L. Hebert, C. Hebert, 2007, Nature Clinical Practice Nephrology.

Sensitive and Specific Real-Time Polymerase Chain Reaction Assays to Accurately Determine Copy Number Variations (CNVs) of Human Complement C4A, C4B, C4-Long, C4-Short, and RCCX Modules: Elucidation of C4 CNVs in 50 Consanguineous Subjects with Defined HLA Genotypes

H. Nagaraja, B. Rovin, D. Birmingham, 2007 .

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).

B. Rovin, L. Juncos, J. Lieske, 2015, Nephron.

The Management of Bacterial Infection-Associated Glomerulonephritis

L. Hebert, S. Parikh, A. Alvarado, 2017 .

L. Hebert, T. Nadasdy, 2011, Seminars in nephrology.

Oral Cyclophosphamide Is on the Verge of Extinction as Therapy for Severe Autoimmune Diseases (Especially Lupus): Should Nephrologists Care?

B. Rovin, L. Hebert, 2010, Nephron Clinical Practice.

Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option.

B. Rovin, K. Hackshaw, L. Hebert, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria.

H. Nagaraja, L. Hebert, D. Sedmak, 2000, Kidney international.

In Reply to 'Expanding the Domain of Postinfectious Glomerulonephritis' and 'Postinfectious Versus Infection-Related Glomerulonephritis'.

L. Hebert, R. Glassock, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effect of moderate daily exercise on acute glomerulonephritis.

R. Fitts, L. Hebert, J. Garancis, 1981, Nephron.

Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy.

L. Hebert, D. Sedmak, J. Plaza, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Diagnostic significance of hypocomplementemia.

F. Cosio, J. Neff, L. Hebert, 1991, Kidney international.

Random Spot Urine Protein/Creatinine Ratio Is Unreliable for Estimating 24-Hour Proteinuria in Individual Systemic Lupus Erythematosus Nephritis Patients

H. Nagaraja, B. Rovin, D. Birmingham, 2009, Nephron Clinical Practice.

Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus.

H. Nagaraja, B. Rovin, D. Birmingham, 2005, Kidney international.

Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis Flare

B. Rovin, L. Hebert, I. Ayoub, 2019, Current Rheumatology Reports.

Management of Lupus Nephropathy

L. Hebert, 2003, Nephron Clinical Practice.

Mycophenolate therapy of SLE membranous nephropathy.

B. Rovin, L. Hebert, Yuxiao Tang, 2004, Kidney international.

Measurement of SC5b-9 in urine in patients with the nephrotic syndrome.

F. Cosio, L. Hebert, D. Sedmak, 1991, Kidney international.

Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE—histologic indicator for antiphospholipid antibodies

B. Rovin, L. Hebert, S. Brodsky, 2018, Lupus.

Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus.

E. Lewis, L. Hebert, J. Peter, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Brodifacoum Induces Early Hemoglobinuria and Late Hematuria in Rats: Novel Rapid Biomarkers of Poisoning

B. Rovin, L. Hebert, D. Feinstein, 2015, American Journal of Nephrology.

Studies of the mechanism by which phosphate infusion lowers serum calcium concentration.

L. Hebert, J. Lemann, E. J. Lennon, 1966, The Journal of clinical investigation.

Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker.

B. Rovin, L. Hebert, 2007, Kidney international.

Uric acid and cardiovascular risk.

B. Rovin, L. Hebert, 2009, The New England journal of medicine.

Effect of glucocorticoids on WBC counts in splenectomized renal transplant recipients.

L. Hebert, W. Piering, J. Lemann, 1978, Archives of internal medicine.

Of mice and men: The relevance of the mouse to the study of human SLE

B. Rovin, D. Birmingham, C. Y. Yu, 2001, Immunologic research.

Response to Dr. Brenner’s Comments

B. Rovin, L. Hebert, C. Hebert, 2004 .

Unexpected renal biopsy findings in a febrile systemic lupus erythematosus patient with worsening renal function and heavy proteinuria.

L. Hebert, D. Sedmak, W. Bay, 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Erratum: Classification of Lupus Nephritis: The classification of glomerulonephritis in systemic lupus erythematosus revisited (Journal of the American Society of Nephrology (2004) 15 (241-250))

V. D’Agati, C. Alpers, L. Looi, 2004 .

Discrepancies in glomerular and tubulointerstitial/vascular immune complex IgG subclasses in lupus nephritis

B. Rovin, L. Hebert, S. Brodsky, 2011, Lupus.

Optimizing ACE-inhibitor therapy for chronic kidney disease.

L. Hebert, 2006, The New England journal of medicine.

Biomarker Discovery for Lupus Nephritis Through Longitudinal Urine Proteomics

H. Nagaraja, D. Birmingham, L. Hebert, 2009 .

Is fluid overload as measured by bioimpedance spectroscopy harmful in CKD-if so, why?

L. Hebert, Samir M. Parikh, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Spot Urine Protein/Creatinine Ratio Testing at a Large University Medical Center: Evidence for Overuse of This Low-Value Diagnostic Test

L. Hebert, JoAnna D. Williams, I. Ayoub, 2020, Kidney international reports.

N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy.

B. Rovin, L. Hebert, S. Brodsky, 2013, American journal of physiology. Renal physiology.

Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?

B. Rovin, L. Hebert, S. Brodsky, 2015, American journal of hypertension.

5/6 Nephrectomy as a Validated Rat Model Mimicking Human Warfarin-Related Nephropathy

B. Rovin, L. Hebert, S. Brodsky, 2012, American Journal of Nephrology.

B. Rovin, L. Hebert, U. Bhatt, 2011, Journal of the American Society of Nephrology : JASN.

Warfarin Therapy That Results in an International Normalization Ratio above the Therapeutic Range Is Associated with Accelerated Progression of Chronic Kidney Disease

B. Rovin, L. Hebert, U. Bhatt, 2010, Nephron Clinical Practice.

Some hemodynamic determinants of immune complex trapping by the kidney.

L. Hebert, S. Koethe, C. Allhiser, 1978, Kidney international.

Platelet involvement in experimental immune complex-mediated glomerulonephritis in the nonhuman primate.

F. Cosio, D. Birmingham, L. Hebert, 1993, Kidney international.

Renal expansion in saline loading.

L. Hebert, K. A. Stuart, J. Stemper, 1974, The American journal of physiology.

Fibrillary Glomerulonephritis with Splenic Involvement: A Detailed Autopsy Study

L. Hebert, C. Hitchcock, T. Nadasdy, 2008, Ultrastructural pathology.

Angiotensin as a Possible Intrarenal Hormone in Isolated Dog Kidneys

L. Hebert, J. Mcgiff, H. Itskovitz, 1973, Circulation Research.

CHARACTERIZATION AND CLINICAL APPLICATION OF THE ???SIGNIFICANCE BAND??? FOR ACUTE RESPIRATORY ALKALOSIS

W. Schwartz, L. Hebert, G. Arbus, 1970 .

Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates.

F. Cosio, D. Birmingham, L. Hebert, 1990, Journal of immunology.

Complement depletion accelerates the clearance of immune complexes from the circulation of primates.

D. Birmingham, L. Hebert, E. Kraut, 1984, The Journal of clinical investigation.

Factors influencing the binding of large immune complexes to the primate erythrocyte CR1 receptor.

D. Birmingham, L. Hebert, J. Cornacoff, 1984, Clinical immunology and immunopathology.

Light-chain proteinuria: spurious false-negative reaction to sulfosalicylic acid.

N. Nahman, J. Neff, L. Hebert, 1985, Annals of internal medicine.

Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia.

N. Nahman, L. Hebert, D. Sedmak, 1997, Journal of the American Society of Nephrology : JASN.

Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans.

Bi Zhou, H. Nagaraja, B. Rovin, 2007, American journal of human genetics.

Chapter 19 – Complement Deficiencies in Human Systemic Lupus Erythematosus (SLE) and SLE Nephritis: Epidemiology and Pathogenesis

B. Rovin, D. Birmingham, C. Y. Yu, 2007 .

Sensitive and specific real-time PCR assays to accurately determine gene copy-number variations (CNVs) of human complement C4A, C4B, C4-Long, C4-Short and RCCX modules: Elucidation of C4 GCNVs in 50 consanguineous subjects with defined HLA genotypes

H. Nagaraja, B. Rovin, C. Y. Yu, 2007 .

Habitual excessive dietary salt intake and blood pressure levels in renal transplant recipients.

J. Kalbfleisch, L. Hebert, W. Piering, 1982, The American journal of medicine.

Therapy of membranous nephropathy: what to do after the after (meta) analyses.

L. Hebert, 1995, Journal of the American Society of Nephrology : JASN.

Response to ‘Aren't we forgetting ACE inhibitor's dark side’?

B. Rovin, L. Hebert, 2008 .

Intensive blood-pressure control in hypertensive chronic kidney disease.

Keith C. Norris, Jackson T. Wright, B. Astor, 2010, The New England journal of medicine.

Anti−PD-1 Immunotherapy May Induce Interstitial Nephritis With Increased Tubular Epithelial Expression of PD-L1

B. Rovin, L. Hebert, G. Lozanski, 2019, Kidney international reports.

IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression

B. Rovin, L. Hebert, S. Brodsky, 2013, Modern Pathology.

Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate.

F. Cosio, D. Birmingham, L. Hebert, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Loin pain-hematuria syndrome associated with thin glomerular basement membrane disease and hemorrhage into renal tubules.

F. Cosio, L. Hebert, D. Sedmak, 1996, Kidney international.

The erythrocyte-immune complex-glomerulonephritis connection in man.

L. Hebert, G. Cosío, 1987, Kidney international.

The living donor in kidney transplantation.

L. Hebert, W. Bay, 1987, Annals of internal medicine.

B. Rovin, L. Hebert, U. Bhatt, 2011, Kidney international.

Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.

N. Nahman, L. Hebert, M. Reif, 1996, Journal of the American Society of Nephrology : JASN.

CR1 and CR1‐like: the primate immune adherence receptors

D. Birmingham, L. Hebert, 2001, Immunological reviews.

Typing of amyloidosis in renal biopsies: diagnostic pitfalls.

L. Hebert, T. Nadasdy, A. Satoskar, 2009, Archives of pathology & laboratory medicine.

Nutritional Management of Water, Sodium, Potassium, Chloride, and Magnesium in Kidney Disease and Kidney Failure

L. Hebert, N. Haddad, Rosemarie L. Shim, 2013 .

Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases

C. Y. Yu, L. Hebert, Yee-Ling Wu, 2016, Front. Immunol..

The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Lee Hebert, Hirofumi Makino, Agnes B Fogo, 2004, Journal of the American Society of Nephrology : JASN.

Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus.

Murugesan V. S. Rajaram, B. Rovin, D. Birmingham, 2013, Molecular immunology.

H. Nagaraja, B. Rovin, D. Birmingham, 2007, The Journal of Immunology.

A Dinucleotide Deletion in CD24 Confers Protection against Autoimmune Diseases

Yang Liu, Xincheng Zheng, Pan Zheng, 2007, PLoS genetics.

Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).

Lee Hebert, G. Eknoyan, T. Hostetter, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Henoch-Schönlein purpura-like presentation in IgA-dominant Staphylococcus infection - associated glomerulonephritis - a diagnostic pitfall.

B. Rovin, L. Hebert, S. Brodsky, 2013, Clinical nephrology.

Whole kidney volume/pressure relationships.

L. Hebert, K. A. Stuart, J. Stemper, 1975, Kidney international.

Urine chemokines as biomarkers of human systemic lupus erythematosus activity.

H. Nagaraja, B. Rovin, D. Birmingham, 2005, Journal of the American Society of Nephrology : JASN.

Stretching of Glomerular Afferent Arterioles in the Swollen Renal Allograft Undergoing Acute Rejection

L. Hebert, A. Laporta, A. L. Riley, 1979, Circulation research.

Renal subcapsular pressure--a new intrarenal pressure measurement.

L. Hebert, G. Arbus, 1971, American Journal of Physiology.

Effect of renal decapsulation on renal function.

L. Hebert, K. A. Stuart, J. Stemper, 1975, The American journal of physiology.

Effect of expansion of renal parenchymal volume on renal function.

L. Hebert, H. Itskovitz, A. L. Riley, 1978, Nephron.

End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1

John D Reveille, Carl D Langefeld, Barry I Freedman, 2014, Arthritis & rheumatology.

The Complement System in Lupus Nephritis.

D. Birmingham, L. Hebert, 2015, Seminars in Nephrology.

The role of the complement system in renal injury.

F. Cosio, D. Birmingham, L. Hebert, 1992, Seminars in nephrology.

Primate erythrocyte-immune complex-clearing mechanism.

D. Birmingham, L. Hebert, W. Smead, 1983, The Journal of clinical investigation.

Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients.

D. Birmingham, L. Hebert, J. Dillon, 1996, Kidney international.

Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35).

F. Cosio, D. Birmingham, L. Hebert, 1994, Journal of the American Society of Nephrology : JASN.

Effect of recombinant erythropoietin therapy on autoimmunity in systemic lupus erythematosus.

D. Birmingham, L. Hebert, D. Sedmak, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.

Keith C. Norris, L. Appel, J. Lewis, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

T. Greene, L. Hebert, S. Massry, 1995, Annals of internal medicine.

The intricate role of complement component C4 in human systemic lupus erythematosus.

B. Rovin, D. Birmingham, C. Y. Yu, 2004, Current directions in autoimmunity.

Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus

H. Nagaraja, B. Rovin, D. Birmingham, 2009, Cytogenetic and Genome Research.

Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli.

F. Cosio, D. Birmingham, L. Hebert, 1986, The Journal of clinical investigation.

Infantile polycystic kidney disease in the adult.

L. Hebert, W. Piering, J. Lemann, 1977, Archives of internal medicine.

D-dimer level and the risk for thrombosis in systemic lupus erythematosus.

B. Rovin, D. Birmingham, K. Hackshaw, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Biomarkers of lupus nephritis determined by serial urine proteomics.

H. Nagaraja, B. Rovin, D. Birmingham, 2008, Kidney international.

Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort.

J. Lewis, T. Greene, R. Toto, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Experimental immune complex-mediated glomerulonephritis in the nonhuman primate.

F. Cosio, D. Birmingham, L. Hebert, 1991, Kidney international.

Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function.

L. Hebert, J. Dominguez, H. Kauffman, 1976, JAMA.

Glomerular basement membrane splitting and microaneurysm formation associated with nitrosourea therapy.

L. Hebert, W. Bay, H. Sharma, 1985, American journal of nephrology.

When Size Matters: Diagnostic Value of Kidney Biopsy according to the Gauge of the Biopsy Needle

B. Rovin, L. Hebert, S. Brodsky, 2013, American Journal of Nephrology.

Bacterial endocarditis manifesting as autoimmune pulmonary renal syndrome: ANCA-associated lung hemorrhage and pauci-immune crescentic glomerulonephritis .

L. Hebert, A. Satoskar, I. Ayoub, 2018, Clinical nephrology.

Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.

H. Nagaraja, B. Rovin, D. Birmingham, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Relationship of Circulating AntiC 3 b and AntiC 1 q IgG to Lupus Nephritis and Its Flare

H. Nagaraja, B. Rovin, D. Birmingham, 2015 .

Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.

R. Bain, E. Lewis, A. Levey, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Anticoagulant-Related Nephropathy.

J. Eikelboom, L. Hebert, S. Brodsky, 2018, Journal of the American Society of Nephrology : JASN.

B. Rovin, L. Hebert, Haifeng M. Wu, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Plasmapheresis in the treatment of renal allograft rejection.

P. Tomasulo, L. Hebert, H. Kauffman, 1979, Proceedings of the Clinical Dialysis and Transplant Forum.

The clearance of immune complexes from the circulation of man and other primates.

L. Hebert, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Stability of renal transplant function with alternate-day corticosteroid therapy.

J. Kalbfleisch, L. Hebert, H. Kauffman, 1980, JAMA.

Renal artery dissection causing renal infarction in otherwise healthy men.

N. Nahman, L. Hebert, P. Baker, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy

B. Rovin, L. Hebert, S. Brodsky, 2017, Kidney research and clinical practice.

An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathy.

L. Hebert, T. Nadasdy, G. Nadasdy, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Anticoagulant-Related Nephropathy in Kidney Biopsy: A Single-Center Report of 41 Cases

B. Rovin, L. Hebert, S. Brodsky, 2019, Kidney medicine.

Protecting the kidneys in lupus nephritis

B. Rovin, L. Hebert, S. Parikh, 2011 .

Renal autotransplantation in the loin pain-hematuria syndrome: a cautionary note.

L. Hebert, D. Sedmak, E. Elkhammas, 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes.

F. Cosio, D. Birmingham, L. Hebert, 1987, Journal of immunology.

Renoprotection: one or many therapies?

N. Nahman, B. Rovin, L. Hebert, 2001, Kidney international.

Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group.

E. Lewis, L. Hebert, D. Sedmak, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus

R. Cantor, B. Rovin, F. Arnett, 2007, Proceedings of the National Academy of Sciences.

BP Control and Long-Term Risk of ESRD and Mortality.

L. Appel, G. Bakris, D. Glidden, 2017, Journal of the American Society of Nephrology : JASN.

Biomarker discovery in human SLE nephritis.

H. Nagaraja, B. Rovin, D. Birmingham, 2007, Bulletin of the NYU hospital for joint diseases.

Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease.

B. Astor, T. Erlinger, G. Bakris, 2010, Journal of the American Society of Nephrology : JASN.

Biologic significance of the erythrocyte complement receptor: a primate perquisite.

F. Cosio, D. Birmingham, L. Hebert, 1991, Journal of Laboratory and Clinical Medicine.

A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.

H. Nagaraja, B. Rovin, D. Birmingham, 2007, Molecular immunology.

Rate of antigen entry into the circulation in experimental versus naturally occurring immune complex glomerulonephritis.

F. Cosio, D. Birmingham, L. Hebert, 1994, Journal of the American Society of Nephrology : JASN.

Effect of chronically increased erythrocyte complement receptors on immune complex nephritis.

F. Cosio, D. Birmingham, L. Hebert, 1994, Kidney international.

Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review

B. Rovin, L. Hebert, Hashim M Mehter, 2008, Rheumatology International.

Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy.

H. Nagaraja, B. Rovin, D. Birmingham, 2005, Kidney international.

Revisiting medullary tophi: a link between uric acid and progressive chronic kidney disease?

B. Rovin, L. Hebert, S. Brodsky, 2016, Clinical nephrology.

An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis.

B. Rovin, P. Hebert, D. Birmingham, 2011, Arthritis and rheumatism.

Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares.

H. Nagaraja, B. Rovin, M. Bissell, 2007, Kidney international.

Usual ACE Inhibitor Therapy in CKD Patients Is Associated with Lower Plasma Aldosterone Levels than Usual Angiotensin Receptor Blocker Therapy

H. Nagaraja, L. Hebert, N. Haddad, 2007, Kidney and Blood Pressure Research.

Immune complexes bind preferentially to specific subpopulations of human erythrocytes.

F. Cosio, L. Hebert, X. P. Shen, 1990, Clinical immunology and immunopathology.

Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare

L. Hebert, H. Nagaraja, B. Rovin, 2006, Clinical and experimental immunology.

Effects of immune complex formation and complement activation on circulating platelets in the primate.

D. Birmingham, L. Hebert, P. Higgins, 1999, Clinical immunology.

Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates.

F. Cosio, D. Birmingham, L. Hebert, 1990, The Journal of laboratory and clinical medicine.

Short-term prognosis of severe proliferative lupus nephritis.

E. Lewis, L. Hebert, B. Kasinath, 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hypertension And The Kidney: Reduced Kidney Mass Is Bad For Both Normotensive And Hypertensive Rats.

L. Hebert, V. Yildiz, S. Brodsky, 2021, American journal of hypertension.

High urine volume and low urine osmolality are risk factors for faster progression of renal disease.

A. Levey, T. Greene, L. Hebert, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease.

R. Cantor, J. Rioux, J. Kere, 2005, Arthritis and rheumatism.

Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.

M. Bissell, L. Hebert, D. Benson, 2013, Archives of pathology & laboratory medicine.

Progression of Kidney Disease: Diagnosis and Management

L. Hebert, N. Haddad, A. Agarwal, 2009 .

Management of Glomerular Proteinuria: A Commentary

B. Rovin, L. Hebert, C. Hebert, 2003 .

Increased INR>3.0 In Patients on Warfarin Therapy Is Associated with Acute Changes In the Serum Creatinine and Increased Mortality Rate

L. Hebert, Haifeng M. Wu, S. Brodsky, 2010 .

Anticoagulant-Related Nephropathy: Is an AKI Elephant Hiding in Plain View?

L. Hebert, S. Brodsky, 2016, Journal of the American College of Cardiology.

Screening for cognitive impairment in SLE using the Self-Administered Gerocognitive Exam

B. Rovin, L. Hebert, A. Meara, 2018, Lupus.

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.

B. Rovin, L. Juncos, J. Lieske, 2019, The New England journal of medicine.

Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.

B. Rovin, L. Hebert, A. Agarwal, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications.

H. Nagaraja, B. Rovin, M. Bissell, 2008, Clinical journal of the American Society of Nephrology : CJASN.

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.

G. Bakris, L. Hebert, I. Janssen, 2000, Kidney international.

Adverse effect of exercise on immune complex-mediated glomerulonephritis.

L. Hebert, W. Bay, H. Sharma, 1985, Nephron.

Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis.

B. Rovin, D. Birmingham, L. Hebert, 2012, Rheumatology.

Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy.

L. Hebert, D. Sedmak, J. Plaza, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis.

H. Nagaraja, B. Rovin, L. Hebert, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Safety and tolerance of medical nutritional products as sole sources of nutrition in people on hemodialysis.

L. Hebert, M. K. Hensley, R. Kunau, 1998, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Rapidly progressive glomerulonephritis superimposed on diabetic glomerulosclerosis. Recognition and treatment.

L. Hebert, J. Garancis, W. Piering, 1982, JAMA.

Simple method for monitoring 24-hour urinary urea nitrogen excretion.

L. Hebert, R. Zager, J. Hartman, 1986, The Journal of laboratory and clinical medicine.

The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare

H. Nagaraja, B. Rovin, D. Birmingham, 2021, Kidney international reports.

Stimulating erythropoiesis increases complement receptor expression on primate erythrocytes.

F. Cosio, D. Birmingham, L. Hebert, 1992, Clinical immunology and immunopathology.

Use of computer graphics to assess trends in glomerular filtration rate (GFR) from sequential serum creatinine values

J. Lott, L. Hebert, S. Baer, 1984 .

Anti−PD-1 Immunotherapy May Induce Interstitial Nephritis With Increased Tubular Epithelial Expression of PD-L1

B. Rovin, L. Hebert, G. Lozanski, 2019, Kidney international reports.